403661001: Lipoatrophy caused by injected drug (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \General finding of soft tissue\Subcutaneous tissue finding (finding)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \General finding of soft tissue\Disorder of soft tissue\Lipoatrophy\Localised lipoatrophy\Lipoatrophy due to injected drug
• \General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \Procedure related finding\Disorder following clinical procedure\Adverse reaction following injection of substance\Lipoatrophy due to injected drug
• \Integumentary system finding\Subcutaneous tissue finding (finding)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \Disease\Degenerative disorder\Lipoatrophy\Localised lipoatrophy\Lipoatrophy due to injected drug
• \Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \Disease\Disorder following clinical procedure\Adverse reaction following injection of substance\Lipoatrophy due to injected drug
• \Disease\Adverse reaction (disorder)\Adverse reaction following injection of substance\Lipoatrophy due to injected drug
• \Disease\Adverse reaction (disorder)\Adverse reaction to drug\Lipoatrophy due to injected drug
• \Disease\Disorder of connective tissue (disorder)\Lipoatrophy\Localised lipoatrophy\Lipoatrophy due to injected drug
• \Disease\Disorder of connective tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug
• \Disease\Disorder of soft tissue\Lipoatrophy\Localised lipoatrophy\Lipoatrophy due to injected drug
• \Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue (disorder)\Disorder of subcutaneous tissue (disorder)\Subcutaneous fat disorder\Lipoatrophy due to injected drug

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
1782677014	Lipoatrophy due to injected drug	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3292438014	Lipoatrophy caused by injected drug	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3295346015	Lipoatrophy caused by injected drug (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4213495017	Drug-induced localised lipoatrophy	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4213496016	Drug-induced localized lipoatrophy	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4213499011	A rare localised lipodystrophy characterised by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin colouration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4213500019	A rare localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start